Showing results (1-10 of 2,011) with videos related to

Sort By:
Pageof 202
Journal of the American College of Cardiology|June 1, 1997
Predictors of graft patency 3 years after coronary artery bypass graft surgery. Department of Veterans Affairs Cooperative Study Group No. 297S Goldman, K Zadina, B Krasnicka, et al.
Circulation|November 1, 1989
Saphenous vein graft patency 1 year after coronary artery bypass surgery and effects of antiplatelet therapy. Results of a Veterans Administration Cooperative StudyS Goldman, J Copeland, T Moritz, et al.
Circulation|June 1, 1988
Improvement in early saphenous vein graft patency after coronary artery bypass surgery with antiplatelet therapy: results of a Veterans Administration Cooperative StudyS Goldman, J Copeland, T Moritz, et al.
Controlled Clinical Trials|September 1, 1988
The statistical analysis of graft patency data in a clinical trial of antiplatelet agents following coronary artery bypass graftingW G Henderson, T Moritz, S Goldman, et al.
Circulation|August 1, 1991
Starting aspirin therapy after operation. Effects on early graft patency. Department of Veterans Affairs Cooperative Study GroupS Goldman, J Copeland, T Moritz, et al.
Circulation|March 1, 1994
Long-term graft patency (3 years) after coronary artery surgery. Effects of aspirin: results of a VA Cooperative studyS Goldman, J Copeland, T Moritz, et al.
Circulation|November 1, 1990
Internal mammary artery and saphenous vein graft patency. Effects of aspirinS Goldman, J Copeland, T Moritz, et al.
The Annals of Thoracic Surgery|May 1, 1991
Comparison of postoperative complications between saphenous vein and IMA grafts to left anterior descending coronary arteryG K Sethi, J G Copeland, T Moritz, et al.
Journal of the American College of Cardiology|January 1, 1990
Implications of preoperative administration of aspirin in patients undergoing coronary artery bypass grafting. Department of Veterans Affairs Cooperative Study on Antiplatelet TherapyG K Sethi, J G Copeland, S Goldman, et al.
Controlled Clinical Trials|October 1, 1995
Use of cumulative meta-analysis in the design, monitoring, and final analysis of a clinical trial: a case studyW G Henderson, T Moritz, S Goldman, et al.
Pageof 202